Logo

Atlas Biolabs Adds Agilent Platform to Expression Profiling Services

Aug 20, 2008

NEW YORK (GenomeWeb News) – German genomics services firm Atlas Biolabs said today that it has added Agilent Technologies’ microarray platform to its expression profiling services.

The Agilent platform joins competing platforms sold by Affymetrix and Illumina as part of Atlas’ offerings. In addition to offering catalog and custom chips from the microarray manufacturers, Atlas said it provides customers with chip design in custom array formats and a detailed analysis of the expression data.

Further terms of the agreement were not disclosed.

Breaking News
The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.